The Chang Robotics Fund Invests in Hibiscus Health to Reimagine Preventive Care

Hibiscus Health is making preventive care as easy as a selfie, and the Chang Robotics Fund is all in on the vision.

Hibiscus Health is making preventive healthcare more accessible, and the Chang Robotics Fund is excited to help scale their impact. More than 98 million U.S. adults have pre-diabetes, yet 80% are unaware of it. Additionally, workplace health programs are often reactive and slow to identify chronic conditions before they escalate. Hibiscus Health tackles this by making early detection effortless, inclusive, and proactive. Using a non-invasive facial scan that detects metabolic risk factors, they empower employers to identify risks earlier, enhance employee health, and achieve significant cost savings through proactive care.

Hibiscus Health is uniquely positioned to transform preventive care with its AI-powered facial scan, which can detect factors such as elevated blood sugar, blood pressure, cholesterol, and triglycerides in under 30 seconds, without the need for labs, needles, or in-person visits. This platform has demonstrated strong engagement and outcomes, with 95% of users reporting improved wellness within 60 days, and over two-thirds uncovering previously undetected health risks. Its non-invasive approach delivers personalized care pathways, making it a scalable solution that meets employees wherever they are.

The Chang Robotics Fund’s partnership with Hibiscus Health aligns with our commitment to back transformative technologies that address real challenges, and the importance of early detection of metabolic health risks cannot be overstated. Kavi Misri, Founder of Hibiscus Health, is a serial health-tech entrepreneur with a successful exit under his belt, and he has built a phenomenal team around him to help the company scale.  

This partnership is also strategically aligned with the existing work Chang Robotics is doing to automate operations and solve labor challenges across the healthcare sector. We look forward to working closely to develop hardware solutions and explore additional use cases that will help expand commercial access and de-risk the path to scale.  

By focusing on early detection and personalized care, Hibiscus Health addresses a critical gap in the market, offering a scalable solution that can significantly reduce healthcare costs for payers while improving long-term outcomes for users. We look forward to a future where healthcare is more proactive, personalized, and accessible. Hibiscus Health is making that future a reality.  

The Capital from the Chang Robotics Fund will enable Hibiscus Health to expand its sales and marketing efforts, enhance its AI-powered platform, and validate its impact through additional clinical studies. These growth initiatives will help catalyze their mission to make proactive, preventive care mainstream and measurable at scale.

Kavi Mirsi - CEO and Founder

"Receiving support from the Chang Robotics Fund is a powerful validation of our mission to make preventive healthcare accessible, inclusive, and proactive. This capital enables us to scale faster, reach more lives, and challenge a system that too often waits until it’s too late. The CR Fund isn’t just a source of capital, it’s a partner in reimagining how, when, and for whom care begins," says Kavi Mirsi, CEO and Founder of Hibiscus Health

It's not too late to join the Fund and support the innovative companies we've handpicked to invest in. However, time is limited! To get in contact, fill out the contact form on our website.

To learn more about Hibiscus Health, visit www.hibiscushealth.com and follow Hibiscus Health on LinkedIn.